[ad_1] (MedPage Today) -- Drug should serve as comparator arm in future studies of adjuvant treatment, experts said Source link [ad_1]
[ad_1] Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study Source link [ad_1]
[ad_1] Capecitabine plus bevacizumab (CAP-B) maintenance treatment after 6 cycles of capecitabine, oxaliplatin, and bevacizumab (CAPOXB) has demonstrated clinical activity and failure to compromise quality of life in... Source link [ad_1]
[ad_1] Capecitabine Induced Enteritis Leading to Small Bowel Obstruction Source link [ad_1]
© 2017 Worldnews Media LLC. All Rights Reserved.